Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print RSS Feed

Breaking News

Related Searches:
December 6, 2010
Ian C. Read succeeds Jeffrey B. Kindler as Pfizer's president and chief executive officer.  Read More »
December 6, 2010
Pfizer achieved positive results from a Phase III study of the investigational compound bosutinib as a first-line treatment in patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).  Read More »
December 6, 2010
Genentech, a member of the Roche Group, achieved positive results from a Phase II study of RG16781, an investigational glycine reuptake inhibitor (GRI) for the treatment of schizophrenia.  Read More »
December 6, 2010
Merrion Pharmaceuticals has entered an oral drug delivery feasibility and option agreement with Rebel Pharmaceuticals, LLC to evaluate the ability of its GIPET technology to boost the bioavailablity of three undisclosed compounds.  Read More »
December 3, 2010
Elena Logan has been appointed senior vice president of global central labs at PPD, Inc.   Read More »
December 3, 2010
BASi (Bioanalytical Systems Inc.) has added three representatives to its business development team.   Read More »
December 3, 2010
HemaQuest Pharmaceuticals, Inc. has added three executives to its management team.  Read More »
December 2, 2010
Baxter International and Takeda Pharmaceutical Co. Ltd. have entered a development, license and technology transfer agreement to bring Vero cell culture-based influenza vaccines to the Japanese market.  Read More »
December 2, 2010
Advinus Therapeutics and Corning Inc. entered a collaboration to bring Corning Epic label-free detection technology to India.   Read More »
December 2, 2010
Applied Pharma Research (APR) and its partner Labtec, a drug delivery developer, have submitted Zolmitriptan Oral Dispersible Film (ODF) for approval in Europe.   Read More »
December 1, 2010
Wesley P. Wheeler, chief executive officer and president of Patheon has left the company.   Read More »
December 1, 2010
Novartis will cut 1,400 jobs in the U.S. as part of a restructuring effort to streamline its business and to focus on specialty medicines.  Read More »
December 1, 2010
Axcan Holdings will acquire all outstanding shares of Eurand for approximately $583 million in cash.  Read More »
December 1, 2010
Pam Tyler, a purchasing manager at DPT Laboratories, was recently recognized by the Drug, Chemical and Associated Technology Association (DCAT) for her service to the organization.   Read More »
November 30, 2010
Chris Beaver, Ph.D. has been appointed director of Immunochemistry Services at PharmaNet Development Group.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On